您好,欢迎光临世界标品! 登录 注册(订药物标准品请用邮件联系我们)

SCITEK INTERNATIONAL (H.K.) LIMITED
Email: sciteck.hongkong@gmail.com
 

当前本网站药物产品种数共 8524 处方药 8148 非处方药 269 保健品/医疗用具 107

世界标品医药目录搜索(中英文):
世界各国官方药品目录搜索(英文):
世界标品医药知识搜索(中英文):

联系方式
国内客服电话:
国际免费电话:

咨询邮箱:
scimed.shanghai@shijiebiaopin.com
info@shijiebiaopin.com
pharmacy.shijiebiaopin1@gmail.com
pharmacy.shijiebiaopin2@gmail.com

  药店国别: 美国药房
产地国家: 美国
所属类别: 抗癌药物->治疗白血病药物
处方药:处方药
包装规格: 50毫克/瓶
计价单位:
   
生产厂家中文参考译名:
SAGENT PHARMA
生产厂家英文名:
SAGENT PHARMA
该药品相关信息网址1:
http://www.drugs.com/pro/fludara.html
该药品相关信息网址2:
http://www.rxlist.com/fludara-drug.htm
该药品相关信息网址3:
http://www.chemocare.com/bio/fludarabine.asp
原产地英文商品名:
FLUDARABINE LYOF POWDER 50MG/VIAL
原产地英文药品名:
FLUDARABINE PHOSPHATE
中文参考商品译名:
氟达拉滨LYOF粉剂 50毫克/瓶
中文参考药品译名:
磷酸氟达拉滨
原产地国家批准上市年份:
0000/00/00
英文适应病症1:
CLL
临床试验期:
完成
中文适应病症参考翻译1:
B细胞性慢性淋巴细胞白血病
药品信息:

---------------------------------------------------------------
 详细处方信息以本药内容附件PDF文件(201242501084937.pdf)的“原文Priscribing Information”为准
---------------------------------------------------------------
部分中文磷酸氟达拉滨处方资料(仅供参考)

商品名:福达华

通用名:磷酸氟达拉滨片

英文名:Fludara

成份:磷酸氟达拉滨Fludarabine phosphate

适应症:用于治疗B细胞性慢性淋巴细胞白血病(CLL),患者在经至少一个疗程含标准烷化剂类化疗方案治疗后或在治疗期间,病情没有改善或持续进展者。

用法用量:
推荐的剂量是每日口服磷酸氟达拉滨40mg/m2体表面积,每28天连续服用5天。磷酸氟达拉滨可以空腹服用或伴食物服用。必须用水吞服,不可嚼服或把药片弄碎后服用。
治疗持续的时间取决于治疗的效果及对药物的耐受性。对CLL患者,磷酸氟达拉滨应一直用到取得最佳治疗效果(完全或部分缓解,通常需6个疗程)后,方可停用。

药物过量:
高剂量的磷酸氟达拉滨与不可逆的中枢神经系统的毒性有关,表现为迟发的失明、昏迷和死亡。高剂量磷酸氟达拉滨还与骨髓抑制造成的严重的血小板减少和粒细胞减少有关。
还没有已知的磷酸氟达拉滨过量的特效拮抗剂,过量的治疗主要包括停用药物和支持治疗。

不良反应:
基于静脉内使用磷酸氟达拉滨的经验,最常见的不良反应包括骨髓抑制(白细胞减少、血小板减少和贫血)、发热、寒战和包括肺炎的感染。其它经常报告的不良反应是水肿、不适、疲倦、虚弱、周围神经病变、视力障碍、食欲不振、恶心、呕吐、腹泻、胃炎和皮肤红斑。磷酸氟达拉滨治疗的患者中有可能出现严重的机会性感染。已经有引起死亡的严重不良反应的报导。

贮藏:密封避光保存

Fludarabine Injection(floo dare' a been)
IMPORTANT WARNING:
Fludarabine injection must be given under the supervision of a doctor who is experienced in giving chemotherapy medications for cancer.

Fludarabine injection can cause a decrease in the number of blood cells made by your bone marrow. This decrease may cause you to develop dangerous symptoms and may increase your risk of having a serious or life-threatening infection. Your doctor may prescribe other medications to decrease the risk that you will develop a severe infection during your treatment. Tell your doctor if you have or have ever had a low number of any type of blood cells in your blood or any condition that affects your immune system and if you have ever developed an infection because your blood cell levels were too low. If you experience any of the following symptoms, call your doctor immediately: shortness of breath; fast heartbeat; headache; dizziness; pale skin; extreme tiredness; unusual bleeding or bruising; black, tarry, or bloody stool; vomit that is bloody or that looks like coffee grounds; and fever, chills, cough, sore throat, difficult, painful, or frequent urination, or other signs of infection.

Fludarabine injection can also cause damage to the nervous system . If you experience any of the following symptoms, call your doctor immediately: seizures, agitation, confusion, and coma (loss of consciousness for a period of time).

Fludarabine injection may cause serious or life-threatening conditions in which the body attacks and destroys its own blood cells. Tell your doctor if you have ever developed this type of condition after receiving fludarabine in the past. If you experience any of the following symptoms, call your doctor immediately: dark urine, yellow skin, tiny red or purple dots on the skin, nosebleeds, heavy menstrual bleeding, blood in the urine, coughing up blood, or difficulty breathing due to bleeding in the throat.

In a clinical study, people with chronic lymphocytic leukemia who used fludarabine injection along with pentostatin (Nipent) were at high risk of developing serious lung damage. In some cases, this lung damage caused death. Therefore, your doctor will not prescribe fludarabine injection to be given along with pentostatin (Nipent).

Keep all appointments with your doctor and the laboratory. Your doctor will order certain tests to check your body's response to fludarabine injection.

Talk to your doctor about the risks of receiving fludarabine injection.

Why is this medication prescribed?
Fludarabine injection is used to treat chronic lymphocytic leukemia (CLL; a type of cancer of the white blood cells) in adults who have already been treated with at least one other medication and have not gotten better. Fludarabine injection is in a class of medications called purine analogs. It works by slowing or stopping the growth of cancer cells in your body.

How should this medicine be used?
Fludarabine injection comes as a powder to be added to fluid and injected over 30 minutes intravenously (into a vein) by a doctor or nurse in a medical office or hospital outpatient clinic. It is usually injected once a day for 5 days in a row. This treatment period is called a cycle, and the cycle may be repeated every 28 days for several cycles.

Your doctor may need to delay your treatment or adjust your dose if you experience certain side effects. Be sure to tell your doctor how you are feeling during your treatment with fludarabine injection.

Other uses for this medicine
Fludarabine injection is also sometimes used to treat non-Hodgkin's lymphoma (NHL; cancer that begins in a type of white blood cell that normally fights infection) and mycosis fungoides (a type of lymphoma that affects the skin). Talk to your doctor about the risks of using this medication for your condition.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

What special precautions should I follow?
Before receiving fludarabine injection,
•tell your doctor and pharmacist if you are allergic to fludarabine, any other medications, or any of the ingredients in fludarabine injection. Ask your pharmacist for a list of the ingredients.
•tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention the medication listed in the IMPORTANT WARNING section or cytarabine (Cytosar-U, DepoCyt). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.
•tell your doctor if you have or have ever had kidney disease.Also tell your doctor about all the other chemotherapy medications you have received and if you have ever been treated with radiation therapy (cancer treatment that uses waves of high energy particles to kill cancer cells). Before you receive chemotherapy or radiation therapy in the future, tell your doctor that you have been treated with fludarabine.
•you should know that fludarabine injection may interfere with the normal menstrual cycle (period) in women and may stop sperm production in men. However, you should not assume that you or your partner cannot become pregnant. If you are pregnant or breast-feeding, you should tell your doctor before you begin receiving this medication. You should not plan to have children while receiving fludarabine injection or for at least 6 months after treatments. Use a reliable method of birth control to prevent pregnancy during this time. Talk to your doctor for further details. Fludarabine injection may harm the fetus.
•if you are having surgery, including dental surgery, tell the doctor or dentist that you are receiving fludarabine injection.
•you should know that fludarabine injection may cause tiredness, weakness, confusion, agitation, seizures, and vision changes. Do not drive a car or operate machinery until you know how this medication affects you.
•talk to your doctor before you receive any vaccinations during your treatment with fludarabine injection.
•you should know that you may develop a serious or life-threatening reaction if you need to receive a blood transfusion during your treatment with fludarabine injection or at any time after your treatment. Be sure to tell your doctor that you are receiving or have received fludarabine injection before you receive a blood transfusion.

What special dietary instructions should I follow?
Unless your doctor tells you otherwise, continue your normal diet.

What side effects can this medication cause?
Fludarabine injection may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
•loss of appetite
•nausea
•vomiting
•constipation
•diarrhea
•mouth sores
•hair loss
•numbness, burning, pain, or tingling in the hands, arms, feet, or legs
•muscle or joint pain
•headache
•depression
•sleep problems

Some side effects can be serious. If you experience any of these symptoms or those listed in the IMPORTANT WARNING section, call your doctor immediately:
•chest pain or discomfort
•fast or irregular heartbeat
•hearing loss
•pain along the side of the body
•swelling of the arms, hands, feet, ankles, or lower legs
•rash
•hives
•difficulty breathing or swallowing
•peeling or blistering skin

Fludarabine injection may cause other side effects. Call your doctor if you have any unusual problems while receiving this medication.

If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online or by phone [1-800-332-1088].

In case of emergency/overdose
In case of overdose, call your local poison control center at 1-800-222-1222. If the victim has collapsed or is not breathing, call local emergency services at 911.

Symptoms of overdose may include:
•unusual bruising or bleeding
•fever, chills, cough, sore throat, or other signs of infection
•delayed blindness
•coma

What other information should I know?
Ask your doctor or pharmacist if you have any questions about fludarabine injection.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Brand names
•Fludara®

.Other names
•2-Fluoro-ara-A Monophosphate, 2-Fluoro-ara AMP, FAMP

---------------------------------------------------------------
 详细处方信息以本药内容附件PDF文件(201242501084937.pdf)的“原文Priscribing Information”为准
---------------------------------------------------------------

更新日期: 2012-4-25
附件:
 
调控比例: 100%
订购表单下载
Copyrights © 2010,2011,2012 www.ShiJieBiaoPin.com, Inc., All rights Reserved www.ShiJieBiaoPin.com, Inc.
客服工作时间:太平洋时间18:00-24:00
国内客服电话:     国际免费电话:
友情提示:以上电话为免费电话,无需您承担任何费用,世界标品提供中文客服,请您放心拨打!
电子邮箱:sciteck.hongkong@gmail.com, 15901965168@163.com